DNA Capital Leads ~USD20m Round Extension for Brazil’s Memed

Source(s): LAVCA

DNA Capital, Temasek and Fit Participações led a ~USD20m round extension for Memed, a Brazil-based provider of digital drug prescriptions. Read more